Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis

Few studies compared adalimumab to other targeted therapies in head-to-head randomized clinical trials (RCTs) for rheumatoid arthritis (RA), but multiple comparisons are not available. This Bayesian Network Meta-Analysis evaluated which targeted therapy is more likely to achieve ACR50 response with...

Descripción completa

Detalles Bibliográficos
Autores principales: Cacciapaglia, Fabio, Venerito, Vincenzo, Stano, Stefano, Fornaro, Marco, Lopalco, Giuseppe, Iannone, Florenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952692/
https://www.ncbi.nlm.nih.gov/pubmed/35330353
http://dx.doi.org/10.3390/jpm12030353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952692/
https://www.ncbi.nlm.nih.gov/pubmed/35330353
http://dx.doi.org/10.3390/jpm12030353

Ejemplares similares